Transforming Growth Factors in the Regulation of Malignant Cell Growth and Invasion

References

• Moses H L, Shipley G D, Leof E B, . Transforming growth factors. Control of Animal Cell Proliferation, A L Boynton, H L Leffert, et al. Academic Press, New York 1987; Vol. D: 75–92
   Google Scholar
• Todaro G J. Autocrine secretion of peptide growth factors by tumor cells. Natl Cancer Inst Monogr 1982; 60: 139–147
   PubMedGoogle Scholar
• Sporn M B, Roberts A B. Autocrine growth factors and cancer. Nature 1985; 313: 745–747
   PubMed Web of Science ®Google Scholar
• Goustin A S, Leof E B, Shipley G D, et al. Growth factors and cancer. Cancer Res 1986; 46: 1015–1029
   PubMed Web of Science ®Google Scholar
• Keski-Oja J, Leof E B, Lyons R M, et al. Transforming growth factors and control of neoplastic cell growth. J Cell Biochem 1987; 33: 95–107
   PubMed Web of Science ®Google Scholar
• Keski-Oja J, Moses H L. Growth inhibitory polypeptides in the regulation of cell proliferation. Med Biol 1987; 65: 13–20
   PubMedGoogle Scholar
• Moses H L, Tucker R F, Leof E B, . Type-β transforming growth factor is a growth stimulator and a growth inhibitor. Growth Factors and Transformation. Cancer Cells 3, J Fermisco, B Ozanne, C Stiles, et al. Cold Spring Harbor Press, Cold Spring Harbor, NY 1985; 65–71
   Google Scholar
• Lengyel P. Biochemistry of interferons and their actions. Ann Rev Biochem 1982; 51: 251–282
   PubMed Web of Science ®Google Scholar
• Taylor-Papadimitriou J. Effects of interferon on cell growth and function. Interferon 2, I Gresser. Academic Press, New York 1980; 13–46
   Google Scholar
• Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986; 320: 584–588
   PubMed Web of Science ®Google Scholar
• Old L M. Tumor necrosis factor (TNF). Science 1985; 230: 630–632
   PubMed Web of Science ®Google Scholar
• Patt L M, Houck J C. The incredible shrinking chalone. FEBS Lett 1980; 120: 163–170
   PubMed Web of Science ®Google Scholar
• Cheifetz S, Weatherbee J A, Tsang M-L, et al. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 1987; 48: 409–415
   PubMed Web of Science ®Google Scholar
• Ikeda T, Lioubin M, Marquardt H. Human transforming growth factor type-β2: Production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry 1987; 26: 2406–2410
   PubMed Web of Science ®Google Scholar
• Padgett R W, St Johnston R D, Gelbart W M. A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor-β family. Nature 1987; 325: 81–84
   PubMed Web of Science ®Google Scholar
• Iverson D H. The Chalones. Handbook of Experimental Pharmacology, R Baserga. Springer Verlag, Berlin 1981; 491–550
   Google Scholar
• Tucker R F, Shipley G D, Moses H L, et al. Growth inhibitor from BSC-1 cells closely related to the platelet type-β transforming growth factor. Science 1984; 226: 705–707
   PubMed Web of Science ®Google Scholar
• Laiho M, Saksela O, Andreasen P A, et al. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol 1986; 103: 2403–2410
   PubMed Web of Science ®Google Scholar
• Laiho M, Saksela O, Keski-Oja J. Transforming growth factor-β alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res 1986; 164: 399–407
   PubMed Web of Science ®Google Scholar
• Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 1985; 823: 35–37
   PubMed Web of Science ®Google Scholar
• Bishop J M. Cellular oncogenes and retroviruses. Ann Rev Biochem 1983; 52: 301–354
   PubMed Web of Science ®Google Scholar
• Doolittle R F, Hunkapiller M W, Hood L E, et al. Simian sarcoma virus one gene, v-sis is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 1983; 221: 275–277
   PubMed Web of Science ®Google Scholar
• Waterfield M D, Scrace G T, Whittle N, et al. Platelet-derived growth factor is structurally related to the putative transforming protein P28JM of simian sarcoma virus. Nature 1983; 304: 35–39
   PubMed Web of Science ®Google Scholar
• Downward J, Yarden Y, Mayes E, et al. Close similarity of epidermal growth factor receptor and v-erfr-B oncogene protein sequences. Nature 1984; 307: 521–527
   PubMed Web of Science ®Google Scholar
• Bargmann C I, Hung M-C, Weinberg R A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986; 319: 226–230
   PubMed Web of Science ®Google Scholar
• Ullrich A, Tarn A W, Downward J, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984; 309: 418–425
   PubMed Web of Science ®Google Scholar
• Weinberger C, Thompson C C, Ong E S, et al. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986; 324: 641–646
   PubMed Web of Science ®Google Scholar
• Sap J, Munoz A, Damm K, et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986; 324: 635–640
   PubMed Web of Science ®Google Scholar
• Sherr C J, Rettenmier C W, Sacca R, et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665–676
   PubMed Web of Science ®Google Scholar
• Greenberg M E, Ziff E B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984; 311: 433–438
   PubMed Web of Science ®Google Scholar
• Kelly K, Cochran B H, Stiles C D, et al. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 1983; 35: 603–610
   PubMed Web of Science ®Google Scholar
• Kruijer W, Cooper J A, Hunter T, et al. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 1984; 312: 711–716
   PubMed Web of Science ®Google Scholar
• Muller R, Bravo R, Burckhardt J, et al. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 1984; 312: 716–720
   PubMed Web of Science ®Google Scholar
• Mulcahy L S, Smith M R, Stacey D W. Requirement for mi proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 1985; 313: 241–243
   PubMed Web of Science ®Google Scholar
• Sager R. Genetic suppression of tumor formation: a new frontier in cancer research. Cancer Res 1986; 46: 1573–1580
   PubMed Web of Science ®Google Scholar
• Shipley G D, Tucker R F, Moses H L. Type β-transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc Natl Acad Sci (USA) 1985; 82: 4147–4151
   PubMed Web of Science ®Google Scholar
• Vaheri A, Keski-Oja J, Vartio T. Fibronectin and malignant transformation. Fibronectin, D F Mosher. Academic Press, New York 1989; 255–271
   Google Scholar
• Shin S, Freedman V H, Risser R, et al. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci (USA) 1975; 72: 4435–4439
   PubMed Web of Science ®Google Scholar
• DeLarco J E, Todaro G J. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci (USA) 1978; 75: 4001–4005
   PubMed Web of Science ®Google Scholar
• Moses H L, Branum E B, Proper J A, et al. Transforming growth factor production by chemically transformed cells. Cancer Res 1981; 41: 2842–2848
   PubMed Web of Science ®Google Scholar
• Todaro G J, DeLarco J E, Marquardt H, et al. Polypeptide growth factors produced by tumor cells and virus-transformed cells: A possible growth advantage for the producer cells. Cold Spring Harbor Conf Cell Prolif 1979; 6: 113–127
   Google Scholar
• Todaro G J, Fryling C, DeLarco J E. Transforming growth factors produced by certain human tumor cells. Polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci (USA) 1980; 77: 5258–5262
   PubMed Web of Science ®Google Scholar
• van Zoelen E JJ, van Oostwaard T MJ, de Laat S W. Transforming growth factor-0 and retinoic acid modulate phenotypic transformation of normal rat kidney ceils induced by epidermal growth factor and platelet-derived growth factor. J Biol Chem 1986; 261: 5003–5009
   PubMed Web of Science ®Google Scholar
• Rizzino A. Behavior of transforming growth factors in serum-free media: An improved assay for transforming growth factors. In Vitro 1984; 20: 815–822
   PubMedGoogle Scholar
• Roberts A B, Anzano M A, Lamb L C, et al. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc Natl Acad Sci (USA) 1981; 78: 5339–5343
   PubMed Web of Science ®Google Scholar
• Anzano M A, Roberts A B, Sporn M B. Anchorage-independent growth of primary rat embryo cells is induced by platelet-derived growth factor inhibited by type-β transforming growth factor. J Cell Physiol 1986; 126: 312–318
   PubMed Web of Science ®Google Scholar
• Rizzino A, Ruff E. Fibroblast growth factor induces the soft agar growth of two non-transformed cell lines. In Vitro Cell Dev Biol 1986; 22: 749–755
   PubMed Web of Science ®Google Scholar
• Leof E B, Proper J A, Goustin A S, et al. Induction of c-wmRNA and activity similar to platelet-derived growth factor by transforming growth factor-β: A proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci (USA) 1986; 83: 2453–2457
   PubMed Web of Science ®Google Scholar
• Assoian R K, Grotendorst G R, Miller D M, et al. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature 1984; 309: 804–806
   PubMed Web of Science ®Google Scholar
• Ignotz R A, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337–4345
   PubMed Web of Science ®Google Scholar
• Anzano M A, Roberts A B, Meyers C A, et al. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res 1982; 42: 4776–4778
   PubMedGoogle Scholar
• Newman M J, Lane E A, Nugent M A, et al. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type-β transforming growth factor in partially transformed rat kidney cells. Cancer Res 1986; 46: 5842–5850
   PubMed Web of Science ®Google Scholar
• Rizzino A, Ruff E, Rizzino H. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-β. Cancer Res 1986; 46: 2816–2820
   PubMed Web of Science ®Google Scholar
• van Zoelen E JJ, van Oostwaard T MJ, de Laat S W. PDGF-like growth factor induces EGF-potentiated phenotypic transformation of normal rat kidney cells in the absence of TGF-β. Biochem Biophys Res Comm 1986; 141: 1229–1235
   PubMed Web of Science ®Google Scholar
• Frolik C A, Roller P P, Cone J L, et al. Inhibition of transforming growth factor-induced cell growth in soft agar by oxidized polyandries. Arch Biochem Biophys 1984; 230: 93–102
   PubMed Web of Science ®Google Scholar
• Roberts A B, Anzano M A, Lamb L C, et al. Antagonistic actions of retinoic acid and dexamethasone on anchorage-independent growth and epidermal growth factor binding of normal rat kidney cells. Cancer Res 1984; 44: 1635–1641
   PubMed Web of Science ®Google Scholar
• Anzano M A, Roberts A B, Smith J M, et al. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type-a and type-β transforming growth factors. Proc Natl Acad Sci (USA) 1983; 80: 6264–6268
   PubMed Web of Science ®Google Scholar
• Roberts A B, Anzano M A, Wakefield L M, et al. Type-0 transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci (USA) 1985; 82: 119–123
   PubMed Web of Science ®Google Scholar
• Hirai R, Yamaoka K, Mitsui H. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line. Cancer Res 1983; 43: 5742–5746
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Hirai R, Tsugita A, et al. The purification of an acid-and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line. J Cell Physiol 1984; 119: 307–314
   PubMed Web of Science ®Google Scholar
• Fryling C M, Iwata K K, Johnson P A, et al. Two distinct tumor cell growth-inhibiting fectors from a human rhabdomyosarcoma cell line. Cancer Res 1985; 45: 2695–2699
   PubMed Web of Science ®Google Scholar
• Iwata K K, Fryling C M, Knott W B, et al. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line. Cancer Res 1985; 45: 2689–2694
   PubMed Web of Science ®Google Scholar
• DeLarco J E, Pigott D A, Lazarus J A. Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype. Proc Nad Acad Sci (USA) 1985; 82: 5015–5019
   PubMed Web of Science ®Google Scholar
• DeLarco J E, Reynolds R, Carlberg K, et al. Sarcoma growth factor from mouse sarcoma virus-transformed cells. Purification by binding and elution from epidermal growth factor receptor-rich cells. J Biol Chem 1980; 255: 2685–2690
   Google Scholar
• Marquardt H, Hunkapiller M W, Hood L E, et al. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: Amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci (USA) 1983; 80: 4684–4688
   PubMed Web of Science ®Google Scholar
• Coffey R J, Derynck R, Wilcox I N, et al. Production and auto-induction of transforming growth factor-a in human tceratinocytes. Nature 1987; 328: 817–820
   PubMed Web of Science ®Google Scholar
• Marquardt H, Hunkapiller M W, Hood L E, et al. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 1984; 223: 1079–1082
   PubMed Web of Science ®Google Scholar
• Derynck R. Transforming growth factor-a: Structure and biological activities. J Cell Biochem 1986; 32: 293–304
   PubMed Web of Science ®Google Scholar
• Lee D C, Rochford R, Todaro G J, et al. Developmental expression of rat transforming growth factor-a mRNA. Mol Cell Biol 1985; 5: 3644–3646
   PubMed Web of Science ®Google Scholar
• Tarn J P. Physiological effects of transforming growth factor-a in the newborn mouse. Science 1985; 229: 673–675
   PubMed Web of Science ®Google Scholar
• Twardzik D R. Differential expression of transforming growth factor-a during prenatal development of the mouse. Cancer Res 1985; 45: 5413–5416
   PubMed Web of Science ®Google Scholar
• Tricoli J V, Nakai H, Byers M G, et al. The gene for human transforming growth factor-a is on the short arm of chromosome 2. Cytogenet Cell Genet 1986; 42: 94–98
   PubMedGoogle Scholar
• Derynck R, Roberts A B, Winkler M E, et al. Human transforming growth factor-a: precursor structure and expression in E coli. Cell 1984; 38: 287–297
   PubMed Web of Science ®Google Scholar
• Scott J, Urdea M, Quiroga M, et al. Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science 1983; 221: 236–240
   PubMed Web of Science ®Google Scholar
• Gray A, Dull T J, Ullrich A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature 1983; 303: 722–725
   PubMed Web of Science ®Google Scholar
• Brown J P, Twardzik D R, Marquardt H, et al. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor-a. Nature 1985; 313: 491–492
   PubMed Web of Science ®Google Scholar
• Reisner A H. Similarity between the vaccinia virus 19K early protein and epidermal growth factor. Nature 1985; 313: 801–803
   PubMed Web of Science ®Google Scholar
• Stroobant P, Rice A P, Gullick W J, et al. Purification and characterization of vaccinia virus growth factor. Cell 1985; 42: 383–393
   PubMed Web of Science ®Google Scholar
• Chang W, Upton C, Hu S, et al. The genome of shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor-a. Mol Cell Biol 1987; 7: 535–540
   PubMed Web of Science ®Google Scholar
• Stromberg K, Hudgins W R, Fryling C M, et al. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-a. J Cell Biochem 1986; 32: 247–259
   PubMed Web of Science ®Google Scholar
• Patthy L. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell 1985; 41: 657–663
   PubMed Web of Science ®Google Scholar
• Assoian R K, Komoriya A, Meyers C A, et al. Transforming growth factor-13 in human platelets Identification of a major storage site, purification and characterization. I Biol Chem 1983; 258: 7155–7160
   Web of Science ®Google Scholar
• Derynck R, Jarrett J A, Chen E Y, et al. Human transforming growth factor-/3 complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–705
   PubMed Web of Science ®Google Scholar
• Fujii D, Brissenden I E, Derynck R, et al. Transforming growth factor-β gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somatic Cell Mol Genetics 1986; 12: 281–288
   PubMedGoogle Scholar
• Sporn M B, Roberts A B, Wakefield L M, et al. Transforming growth factor-β: biological function and chemical structure. Science 1986; 233: 532–534
   PubMed Web of Science ®Google Scholar
• Lawrence D A, Pircher R, Jullien P. Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem Biophys Res Commun 1985; 133: 1026–1034
   PubMed Web of Science ®Google Scholar
• Lawrence D A, Pircher R, Kryceve-Martinerie C, et al. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 1984; 121: 184–188
   PubMed Web of Science ®Google Scholar
• Massague I, Like B. Cellular receptors for type-0 transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. I Biol Chem 1985; 260: 2636–2645
   Google Scholar
• Fanger B O, Wakefield L M, Sporn M B. Structure and properties of the cellular receptor for transforming growth factor type-β. Biochemistry 1986; 25: 3083–3091
   PubMed Web of Science ®Google Scholar
• Cheifetz S, Like B, Massague J. Cellular distribution of type I and type II receptors for transforming growth factor-β. J Biol Chem 1986; 261: 9972–9978
   PubMed Web of Science ®Google Scholar
• Tucker R F, Branum E L, Shipley G D, et al. Specific binding to cultures cells of 125I-labeled transforming growth factor type-β from human platelets. Proc Natl Acad Sci (USA) 1984; 81: 6757–6761
   PubMed Web of Science ®Google Scholar
• Childs C B, Proper I A, Tucker R F, et al. Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci (USA) 1982; 79: 5312–5316
   PubMed Web of Science ®Google Scholar
• Holley R W, Armour R, Baldwin I H. Density-dependent regulation of growth of BSC-1 cells in cell culture: Growth inhibitors formed by the cells. Proc Natl Acad Sci (USA) 1978; 75: 1864–1866
   PubMed Web of Science ®Google Scholar
• Holley R W, Bohlen P, Fava R, et al. Purification of kidney epithelial cell growth inhibitors. Proc Natl Acad Sci (USA) 1980; 77: 5989–5992
   PubMed Web of Science ®Google Scholar
• Derynck R, Jarrett J A, Chen E Y, et al. The murine transforming growth factor-0 precursor. J Biol Chem 1986; 261: 4377–4379
   PubMed Web of Science ®Google Scholar
• Seyedin S M, Thomas T C, Thompson A Y, et al. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci (USA) 1985; 82: 2267–2271
   PubMed Web of Science ®Google Scholar
• Seyedin S M, Segarini P R, Rosen D M, et al. Cartilage-inducing factor-β is a unique protein structurally and functionally related to transforming growth factor-β. J Biol Chem 1987; 262: 1946–1949
   PubMed Web of Science ®Google Scholar
• Mason A J, Hayflick I S, Ling N, et al. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 1985; 318: 659–663
   PubMed Web of Science ®Google Scholar
• Vale Rivier W. J, Vaughan I, et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986; 321: 776–779
   PubMed Web of Science ®Google Scholar
• Ling N, Ying S., Ueno N, et al. Pituitary FSH is released by a heterodimer of β-subunits from the two forms of inhibin. Nature 1986; 321: 779–782
   PubMed Web of Science ®Google Scholar
• Cate R L, Mattaliano R J, Hession C, et al. Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 1986; 45: 685–698
   PubMed Web of Science ®Google Scholar
• Kerhll H, Wakefield L M, Roberts A B, et al. Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037–1050
   PubMed Web of Science ®Google Scholar
• Anzano M A, Roberts A B, De Larco I E, et al. Increased secretion of type-β transforming growth factor accompanies viral transformation of cells. Mol Cell Biol 1985; 5: 242–247
   PubMed Web of Science ®Google Scholar
• Derynck R, Goeddel D V, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 1987; 47: 707–712
   PubMed Web of Science ®Google Scholar
• Knabbe C, Lippman M E, Wakefield L M, et al. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417–428
   PubMed Web of Science ®Google Scholar
• Frolik C A, Wakefield L M, Smith D M, et al. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J Biol Chem 1984; 259: 10995–11000
   PubMed Web of Science ®Google Scholar
• Massague J. Subunit structure of a high-affinity receptor for type-β transforming growth factor. Evidence for disulfide-linked glycosylated receptor complex. J Biol Chem 1985; 260: 7059–7066
   Google Scholar
• Shipley G D, Pittelkow M R, Wille J JJ, et al. Reversible inhibition of normal human prokeratinocyte proliferation by type-β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 1986; 46: 2068–2071
   PubMed Web of Science ®Google Scholar
• Carr B I, Hayashi I, Branum E L, et al. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type-β transforming growth factor. Cancer Res 1986; 46: 2330–2334
   PubMed Web of Science ®Google Scholar
• Frater-Schroden M, Muller G, Birchmeier W, et al. Transforming growth factor-β inhibits endothelial cell proliferation. Biochem Biophys Res Comm 1986; 137: 295–302
   PubMed Web of Science ®Google Scholar
• Masui T, Wakefield L M, Lechner J F, et al. Type-β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci (USA) 1986; 83: 438–442
   Google Scholar
• Builough W S. Mitotic and functional homeostasis: a speculative review. Cancer Res 1965; 25: 1683–1727
   PubMed Web of Science ®Google Scholar
• Anderson P, Yip Y K, Vilcek J. Specific binding of 125I-human interferon-3 to high affinity receptors on human fibroblasts. J Biol Chem 1982; 257: 11301–11304
   PubMed Web of Science ®Google Scholar
• Epstein L B. Interferon-Gamma: is it really different from the other interferons?. Interferon 3, I Gresser. Academic Press, London 1981; 13–44
   Google Scholar
• Kohase M, Henriksen-DeStefano D, May L T, et al. Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 1986; 45: 659–666
   PubMed Web of Science ®Google Scholar
• Knight E J, Anton E D, Fahey D, et al. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc Natl Acad Sci (USA) 1985; 82: 1151–1154
   PubMed Web of Science ®Google Scholar
• Lin S L, Kikuchi T, Pledger W J, et al. Inteferon inhibits the establishment of competence in Go/S-phase transition. Science 1986; 233: 356–359
   PubMed Web of Science ®Google Scholar
• Resnitzky D, Yarden A, Zipori D, et al. Autocrine β-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 1986; 46: 31–40
   PubMed Web of Science ®Google Scholar
• Tominaga S, Lengyel P. β-Interferon alters the pattern of proteins secreted from quiescent and platelet-derived growth factor-treated BALB/C-3T3 cells. J Biol Chem 1985; 260: 1975–1978
   PubMed Web of Science ®Google Scholar
• Einat M, Resnitzky D, Kimchi A L. Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 1985; 313: 597–600
   PubMed Web of Science ®Google Scholar
• Einat M, Resnitzky D, Kimchi A. Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc Natl Acad Sci (USA) 1985; 82: 7608–7612
   PubMed Web of Science ®Google Scholar
• Zullo J N, Cochran B H, Huang A S, et al. Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 1985; 43: 793–800
   PubMed Web of Science ®Google Scholar
• Aggarwal B B, Eessalu T E, Hass P E. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 1985; 318: 665–667
   PubMed Web of Science ®Google Scholar
• Phillip R, Epstein L B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 1986; 323: 86–89
   PubMed Web of Science ®Google Scholar
• Jonak G J, Knight E J. Selective reduction of c-myc mRNA in Daudi cells by human β interferon. Proc Natl Acad Sci (USA) 1984; 81: 1747–1750
   PubMed Web of Science ®Google Scholar
• Beutler B, Greenwald D, Hulmes J D, et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985; 316: 552–554
   PubMed Web of Science ®Google Scholar
• Pennica D, Nedwin G E, Hayflick J S, et al. Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724–729
   PubMed Web of Science ®Google Scholar
• Tracey K J, Beutler B, Lowry S F, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470–474
   PubMed Web of Science ®Google Scholar
• Bertolini D R, Nedwin G E, Bringman T S, et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319: 516–518
   PubMed Web of Science ®Google Scholar
• Creasey A A, Reynolds M T, Laird W. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Cancer Res 1986; 46: 5687–5690
   PubMed Web of Science ®Google Scholar
• Torti F M, Dieckmann B, Beutler B, et al. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 1985; 229: 867–869
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz Z, Williamson B, Carswell E A, et al. Cell cycle-specific effects of tumor necrosis factor. Cancer Res 1984; 44: 83–90
   PubMed Web of Science ®Google Scholar
• Kronke M, Schluter C, Pfizenmaier K. Tumor necrosis factor inhibits myc expression in HL-60 cells at the level of mRNA transcription. Proc Nad Acad Sci (USA) 1987; 84: 469–473
   PubMed Web of Science ®Google Scholar
• Yarden A, Kimchi A. Tumor necrosis factor reduces c-myc expression and cooperates with interferon-γ in HeLa cells. Science 1986; 234: 1419–1421
   PubMed Web of Science ®Google Scholar
• Libby P, Ordovas J M, Auger K R, et al. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986; 124: 179–185
   PubMed Web of Science ®Google Scholar
• Hsu Y, Barry J M, Wang J L. Growth control in cultured 3T3 fibroblasts: Neutralization and identification of a growth-inhibitory factor by a monoclonal antibody. Proc Natl Acad Sci (USA) 1984; 81: 2107–2111
   PubMed Web of Science ®Google Scholar
• McMahon J B, Farrelly J G, Iype P T. Purification and properties of a rat liver protein that specifically inhibits the proliferation of nonmalignant epithelial cells from rat liver. Proc Natl Acad Sci (USA) 1982; 79: 456–460
   PubMed Web of Science ®Google Scholar
• Hsu Y, Wang J L. Growth control in cultured 3T3 fibroblasts V. Purification of an Mr. 13,000 polypeptide responsible for growth inhibitory activity. J Cell Biol 1986; 102: 362–369
   PubMed Web of Science ®Google Scholar
• Zarling J M, Shoyab M, Marquardt H, , Oncostatin M, et al. A growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci (USA) 1986; 83: 9739–9743
   PubMed Web of Science ®Google Scholar
• Kinders R J, Johnson T C. Isolation of celt-surface glycopeptides from bovine cerebral cortex that inhibit cell growth and protein synthesis in normal but not in transformed cells. Biochem J 1982; 206: 527–534
   PubMed Web of Science ®Google Scholar
• Sharifi B G, Johnson T C, Khurana V K, et al. Purification and characterization of a bovine cerebral cortex cell surface sialogly-copeptide that inhibits cell proliferation and metabolism. J Neurochem 1986; 2: 461–469
   Google Scholar
• Reich E. Activation of plasminogen. A general mechanism for producing localized extracellular proteolysis. Molecular Basis of Biological Degradtive Processes, R D Berlin, L Herrman, I H Lepow, J M Tanzer. Academic Press, New York 1980; 155–169
   Google Scholar
• Liotta L A. Tumor invasion and metastases-role of the extracellular matrix. Cancer Res 1986; 46: 1–7
   PubMed Web of Science ®Google Scholar
• Liotta L A, Rao C N, Barsky S H. Tumor invasion and the extracellular matrix. Lab Invest 1983; 49: 636–649
   PubMed Web of Science ®Google Scholar
• Dano K, Andreasen P A, Grondahl-Hansen J, et al. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139–266
   PubMed Web of Science ®Google Scholar
• Wun T C, Ossowski L, Reich E. A proenzyme form of human urokinase. J Biol Chem 1982; 257: 7262–7268
   PubMed Web of Science ®Google Scholar
• Verde P, Stoppelli M P, Galeffi P, et al. Identification and primary sequence of an unspliced human urokinase poly-A + RNA. Proc Nad Acad Sci (USA) 1984; 81: 4727–4731
   PubMed Web of Science ®Google Scholar
• Bergman B L, Scott R W, Bajpai A, et al. Inhibition of rumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I. Proc Natl Acad Sci (USA) 1986; 83: 996–1000
   PubMed Web of Science ®Google Scholar
• Eaton O L, Baker J B. Phorbol esters and mitogens stimulate human fibroblast secretion of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin. J Cell Biol 1983; 97: 313–328
   Google Scholar
• Stoppelli M P, Verde P, Grimaldi G, et al. Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor-promoter phorbol myristate acetate. J Cell Biol 1986; 102: 1235–1241
   PubMed Web of Science ®Google Scholar
• Busso N, Belin D, Failly-Crepin C, et al. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. Cancer Res 1987; 47: 364–370
   PubMed Web of Science ®Google Scholar
• Rifkin D B. Plasminogen activator synthesis by cultured human embryonic lung cells: characterization of the suppressive effect of corticosteroids. J Cell Physiol 1978; 97: 421–428
   PubMed Web of Science ®Google Scholar
• Nagamine Y, Sudol M, Reich E. Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell 1983; 32: 1181–1190
   PubMed Web of Science ®Google Scholar
• Andreasen P A, Christensen T H, Huang J, et al. Hormonal regulation of extracellular plasminogen activators and Mr-54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies. Mol Cell Endocr 1986; 45: 137–147
   PubMed Web of Science ®Google Scholar
• Keski-Oja J, Blasi F, Leof E B, Moses H L. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-β. J Cell Biol 1988; 106: 451–459
   PubMed Web of Science ®Google Scholar
• Keski-Oja J, Raghow R, Sawdey M, et al. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin and procollagen by transforming growth factor-jJ: divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem 1988; 263: 3111–3115
   PubMed Web of Science ®Google Scholar
• Saksela O, Laiho M, Keski-Oja J. Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors. Cancer Res 1985; 45: 2314–2319
   PubMed Web of Science ®Google Scholar
• Cajot J, Kruithof E OK, Schleuning W, et al. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 1986; 38: 719–727
   PubMed Web of Science ®Google Scholar
• van Mourik J A, Lawrence D A, Loskutoff D J. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem 1984; 259: 14914–14921
   PubMed Web of Science ®Google Scholar
• Åstedt B, Lecander I, Brodin T, et al. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Thromb Haemosas 1985; 53: 122–125
   PubMed Web of Science ®Google Scholar
• Scott T W, Baker J B. Purification of human protease nexin. J Biol Chem 1983; 258: 10439–10444
   PubMedGoogle Scholar
• Scott T W, Bergman B L, Bajpai A, et al. Protease nexin. Properties and a modified purification procedure. J Biol Chem 1985; 260: 7029–7034
   Google Scholar
• Laiho M, Saksela O, Keski-Oja J. Transforming growth factor-0 induced type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 1987; 262: 17467–17474
   PubMed Web of Science ®Google Scholar
• Raghow R, Postlethwaite A E, Keski-Oja J, et al. Transforming growth factor-β increases steady-state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 1987; 79: 1285–1288
   PubMed Web of Science ®Google Scholar
• Quigley J P. Phorbol ester-induced morphological changes in transformed chick fibroblasts: Evidence for direct catalytic involvement of plasminogen activator. Cell 1979; 17: 131–141
   PubMed Web of Science ®Google Scholar
• Keski-Oja J, Marquardt H, DeLarco J E, et al. Human fibrosarcoma cells produce fibronectin-releasing peptides. J Supramol Struct 1979; 11: 217–225
   PubMedGoogle Scholar
• Keski-Oja J, Vaheri A. The cellular target for the plasminogen activator, urokinase, in human fibroblasts-66,000 dalton protein. Biochim Biophys Acta 1982; 720: 141–146
   PubMed Web of Science ®Google Scholar
• Lyons R M, Keski-Oja J, Moses H L. Proteolytic activation of latent transforming growth factor-β from fibroblast conditioned medium. J Cell Biol 1988; 106: 1597–1605
   Google Scholar
• Gramse M, Breviario F, Pintucci G, et al. Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells. Biochem Biophys Res Commun 1986; 139: 720–727
   PubMed Web of Science ®Google Scholar
• Nachman R L, Hajjar K A, Silverstein R L, et al. Interleukin-1 induces endothelial cell synthesis of plasminogen activtor inhibitor. J Exp Med 1986; 163: 1595–1600
   PubMed Web of Science ®Google Scholar
• Emeis I I, Kooistra T. Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260–1266
   PubMed Web of Science ®Google Scholar
• Lewis J, Chevallier A, Kieny M, et al. Muscle nerve branches do not devleop in chick wings devoid of muscle. J Embryol Exp Morph 1981; 64: 211–232
   PubMedGoogle Scholar
• Sengel P. Morphogenesis of Skin. Cambridge University Press, Cambridge 1976; 13520–13526
   Google Scholar
• Sumnerbell D, Lewis J H, Walpert I. Positional information in chick morphogenesis. Nature 1973; 244: 492–496
   PubMed Web of Science ®Google Scholar
• Baum J L. Source of the fibroblast in central corneal wound healing. Arch Ophthalmol 1971; 85: 473–477
   PubMed Web of Science ®Google Scholar
• Cohen I K, Moore C D, Diegelmann R F. Onset and localization of collagen synthesis during wound healing in open rat skin wounds. Proc Soc Exp Biol Med 1979; 160: 458–462
   PubMed Web of Science ®Google Scholar
• Schilling J A. Wound healing. Physiol Rev 1968; 48: 374–423
   PubMed Web of Science ®Google Scholar
• Abercrombie M, Heaysman J EM, Pegrum S M. The locomotion of fibroblasts in culture. IV. Electron microscopy of the leading lamella. Exp Cell Res 1971; 67: 359–367
   Google Scholar
• Abercrombie M, Heaysman J EM, Pergrum S M. Locomotion of fibroblasts in culture V. Surface marking with concanavalin A. Exp Cell Res 1972; 73: 536–539
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Snyderman R, Kang A H. The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med 1976; 144: 1188–1203
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Snyderman R, Kang A H. Generation of a fibroblast chemotactic factor in serum by activation of complement. J Clin Invest 1979; 64: 1379–1385
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Kang A H. Fibroblast chemoattractants. Methods Enzymol 1988; 163: 694–707
   PubMed Web of Science ®Google Scholar
• Knowles M A, Hicks R M, Dave H, et al. Transforming growth factors induce markers of neoplasia in cultured adult rat bladder. Carcinogenesis 1985; 6: 595–604
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Kang A H. Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts. J Immunol 1980; 124: 1462–1466
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Seyer J M, Kang A H. Chemotactic attraction of human fibroblasts to type I, II and III collagens and collagen-derived peptides. Proc Natl Acad Sci (USA) 1978; 75: 871–875
   PubMed Web of Science ®Google Scholar
• Seppa H, Seppa S, Yamada K M. The cell binding fragment of fibronectin and platelet-derived growth factor are chemoattractants for fibroblasts. J Cell Biol 1980; 87: 323a
   Web of Science ®Google Scholar
• Senior R M, Griffin G L, Mecham R P. Chemotactic responses of-fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest 1982; 70: 614–618
   PubMed Web of Science ®Google Scholar
• Senior R M, Huang J S, Griffin G L, et al. Dissociation of the chemotactic and mitogenic activities of platelet-derived growth factor by human neutrophil elastase. J Cell Biol 1985; 100: 351–356
   PubMed Web of Science ®Google Scholar
• Mensing H, Czarnetzki B M. Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol 1984; 28: 9–12
   Google Scholar
• Bleiberg I, Harvey A K, Smale G, et al. Identification of a PDGF-like mitoattractant produced by NIH/3T3 cells after transformation with SV40. J Cell Biol 1985; 123: 161–166
   Google Scholar
• Gleiber W E, Schiffmann E. Identification of a chemoattractant for fibroblasts produced by human breast carcinoma cell lines. Cancer Res 1984; 44: 3398–3402
   PubMed Web of Science ®Google Scholar
• Senior R M, Huang S S, Griffin G L, et al. Brain-derived growth factor is a chemoattractant for fibroblasts and astroglial cells. Biochem Biophys Res Comm 1986; 141: 67–72
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Keski-Oja J, Moses H L, et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-β. J Exp Med 1987; 165: 251–256
   PubMed Web of Science ®Google Scholar
• Liotta L A, Mandler R, Murano G, et al. Tumor cell autocrine motility factor. Proc Nad Acad Sci (USA) 1986; 83: 3302–3306
   PubMed Web of Science ®Google Scholar
• Grotendorst G R, Martin G R, Pencev D, et al. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 1985; 76: 2323–2329
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Keslti-Oja J, Balian G, et al. Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000 molecular weight non-gelatin-binding fragment. J Exp Med 1981; 153: 494–499
   PubMed Web of Science ®Google Scholar
• Assoian R K, Sporn M B. Type-β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 1986; 102: 1217–1223
   PubMed Web of Science ®Google Scholar
• Sporn M B, Roberts A B, Shull J H, et al. Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 1983; 219: 1329–1331
   PubMed Web of Science ®Google Scholar
• Leof E B, Proper J A, Getz M J, et al. Transforming growth factor type-β regulation of actin mRNA. I Cell Physiol 1986; 127: 83–88
   PubMed Web of Science ®Google Scholar
• Adelmann-Grill B C, Hein R, Wach F, et al. Inhibition of fibroblast chemotaxis by recombinant human interferon r and interferon α. J. Cell Physiol 1987; 130: 270–275
   PubMed Web of Science ®Google Scholar
• Ignotz R A, Massague J. Type-β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci (USA) 1985; 82: 8530–8534
   PubMed Web of Science ®Google Scholar
• Sparks R, Scott R E. Transforming growth factor type-0 is a specific inhibitor of 3T3 mesenchymal stem cell differentiation. Exp Cell Res 1986; 165: 345–352
   PubMed Web of Science ®Google Scholar
• Florini J R, Roberts A B, Ewton D Z, et al. Transforming growth factor-β: A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by buffalo rat liver cells. J Biol Chem 1986; 261: 16509–16513
   PubMed Web of Science ®Google Scholar
• Olson E N, Sternberg E, Hu J S, et al. Regulation of myogenic differentiation of type-β transforming growth factor. J Cell Biol 1986; 103: 1799–1805
   PubMed Web of Science ®Google Scholar
• Massague J, Cheifetz S, Endo T, et al. Type-0 transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci (USA) 1986; 83: 8206–8210
   PubMed Web of Science ®Google Scholar
• Seyedin S M, Thompson A Y, Bentz H, et al. Cartilage-inducing factor-A: Apparent identity to transforming growth factor-0. J Biol Chem 1986; 261: 5693–5695
   PubMed Web of Science ®Google Scholar
• Kehrl J H, Roberts A B, Wakefield L M, et al. Transforming growth factor-(3 is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986; 137: 3855–3860
   PubMed Web of Science ®Google Scholar
• Rook A H, Kehrl J H, Wakefield L M, et al. Effects of transforming growth factor-β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986; 136: 3916–3920
   PubMed Web of Science ®Google Scholar
• Roberts A B, Sporn M B, Assoian R K, et al. Transforming growth factor type-β rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci (USA) 1986; 83: 4167–4171
   PubMed Web of Science ®Google Scholar
• Thesleff I, Ekblom P, Keski-Oja J. Inhibition of morphogenesis and stimulation of vascular proliferation in embryonic tooth cultures by a sarcoma growth factor preparation. Cancer Res 1983; 43: 5902–5909
   PubMed Web of Science ®Google Scholar